Live Markets
Thursday, July 30, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

China SXT Pharmaceuticals, Inc. (SXTC)

NCM · Drug Manufacturers - Specialty & Generic

$0.05-0.01 (-8.85%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$2.0M
P/E (TTM)
EPS
$-8.27
Div Yield
52W Range
$0.05–$1047.00
Beta
1.82

Company overview

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.

Peers in Drug Manufacturers - Specialty & Generic

All in industry →

Recent press releases

China SXT Pharmaceuticals, Inc. has not issued a press release in this window.

SEC filings

All filings →

China SXT Pharmaceuticals, Inc. has not filed an SEC document in this window.

China SXT Pharmaceuticals, Inc. has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
150,576 sh+208.8%
22,774 sh● NEW
Invesco Ltd.$136,530
85,331 sh-4.8%
818 sh● NEW
53,671 sh0.0%
222 sh+122.0%
12,355 sh-57.4%

People at China SXT Pharmaceuticals, Inc.

All people →

No officers or directors have been indexed for China SXT Pharmaceuticals, Inc..

Quarterly financials

Full financials →
Revenue trend
03/25
$4.3K
NI -$3.3M
RevenueNI = Net Income
EPS trend (diluted)
EPS history not available.
SXTC (NCM) Stock Quote, Press Releases & SEC... | Cayman Journal | Cayman Journal